✦ LIBER ✦

A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors

✍ Scribed by Stephen M. Ansell; Henry C. Pitot; Patrick A. Burch; Larry K. Kvols; Michelle R. Mahoney; Joseph Rubin

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 85 KB
Volume: 91
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20010415)91:8<1543::aid-cncr1163>3.0.co;2-n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of high dose epirubicin

A Phase II trial of high dose epirubicin in patients with advanced breast carcinoma

✍ Kathy D. Miller; Nikhil Munshi; David Loesch; Lawrence H. Einhorn; George W. Sle 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## BACKGROUND. Anthracyclines are among the most active drugs in the treatment of breast carcinoma and exhibit a steep dose-response curve in vitro. This trial was performed to determine the efficacy and toxicity of epirubicin in the treatment of patients with advanced breast carcinoma when adminis

A phase II trial of carboplatin in patie

A phase II trial of carboplatin in patients with advanced APUD tumors

✍ Leonard Saltz; Gregory Lauwers; Jill Wiseberg; David Kelsen 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 1 views

A phase I, II study of high-dose 5-fluor

A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies

✍ Bach Ardalan; Kasi S. Sridhar; Pasquale Benedetto; Stephen Richman; Stuart Waldm 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 1 views

A phase II trial of paclitaxel in patien

A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A southwest oncology group study

✍ Stanley P. Balcerzak; Jacqueline Benedetti; Geoffrey R. Weiss; Ronald B. Natale 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 2 views

A Phase II study of irinotecan in patien

A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma

✍ Eileen M. O'Reilly; Keith E. Stuart; Pedro M. Sanz-Altamira; Gary K. Schwartz; C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

A Phase II study of paclitaxel and ifosf

A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium

✍ Christopher J. Sweeney; Stephen D. Williams; David E. Finch; Richard Bihrle; Ric 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

## BACKGROUND. Cisplatin-based combination chemotherapy for patients with advanced transitional cell carcinoma (TCC) of the urothelium has limitations, and new therapies need to be evaluated. METHODS. Ifosfamide 1.0 gm/m 2 on Days 1-4 and paclitaxel 135 mg/m 2 by 24-hour infusion on Day 4 were ad